Silymarin / Milk Thistle
**Silymarin** is a flavonolignan complex extracted from the seeds of the milk thistle plant (*Silybum marianum*). It is widely utilized in veterinary medicine as a **hepatoprotective nutraceutical**. * **Primary Uses:** Management of acute and chronic hepatopathies, cirrhosis, and inflammatory liver diseases in dogs, cats, and other species. * **Toxin Antidote:** Particularly noted for its critical role as a hepato-protective agent following the ingestion of severe hepatotoxins, such as *Amanita phalloides* (death cap mushrooms). * **Oncology Support:** Emerging laboratory data suggests it may help prevent certain cancers and reduce the hepatotoxic side effects of specific chemotherapy protocols. > **Clinical Pearl:** Because silymarin is a nutraceutical, over-the-counter product quality and bioavailability vary wildly. Veterinary-specific formulations where silybin is complexed with phosphatidylcholine (phytosomes) are highly recommended due to vastly superior gastrointestinal absorption compared to standard extracts.
กลไกการออกฤทธิ์: Silymarin exerts its hepatoprotective effects through multiple synergistic pathways. **Silibinin** (or silybin) is the most biologically active component of the complex. * **Antioxidant & Free Radical Scavenging:** Inhibits lipid peroxidase and beta-glucuronidase. It directly scavenges reactive oxygen species (ROS) and significantly increases intracellular **glutathione** levels in the liver. * **Membrane Stabilization:** Alters the outer hepatocyte cell membrane structure, competitively blocking the binding and transmembrane transport of hepatotoxins (e.g., amatoxins from poisonous mushrooms). * **Anti-inflammatory:** Inhibits the cytotoxic, inflammatory, and apoptotic effects of **Tumor Necrosis Factor-alpha (TNF-α)** and modulates leukotriene synthesis. * **Antifibrotic:** Reduces hepatic stellate cell activation, thereby decreasing hepatic collagen formation and slowing the progression of cirrhosis. * **Regenerative:** Stimulates ribosomal RNA polymerase A → enhances protein synthesis and accelerates hepatocyte regeneration.
ขนาดยาตามชนิดสัตว์
- Therapeutic dosage (general) · 50-250 mg/day · PO · q24h · Suggested dose range
- Adjunctive therapy for chronic liver disease · 20-50 mg/kg per day · PO · q24h · Extrapolated from human, monkey, rodent and dog research
- Chronic liver disease and ameliorating the effects of anticonvulsants · 50-200 mg · PO · q12-24h
- Hepatotoxicity, hepatic recovery/regeneration, hepatic fibrosis · 20-50 mg/kg/day · PO · q24h
- General hepatic support · 4-8 mg/kg/day · PO · q24h
- Therapeutic dosage (general) · 50-250 mg/day · PO · q24h · Suggested dose range
- Adjunctive therapy for chronic liver disease · 20-50 mg/kg per day · PO · q24h · Extrapolated from human, monkey, rodent and dog research
- Chronic liver disease and ameliorating the effects of anticonvulsants · 50-200 mg · PO · q12-24h
- Hepatotoxicity, hepatic recovery/regeneration, hepatic fibrosis · 20-50 mg/kg/day · PO · q24h
ขนาดยาเป็นข้อมูลอ้างอิงทางคลินิกสำหรับสัตวแพทย์ผู้มีใบอนุญาต โปรดตรวจสอบกับฉลากล่าสุดและผู้ป่วยแต่ละรายเสมอ
วิธีการให้ยา
ข้อห้ามใช้
- Known hypersensitivity or allergy to the Asteraceae/Compositae plant family (ragweed, marigolds, daisies)
- Use caution with whole plant extracts (not the seed extract) in patients where exogenous estrogens are contraindicated, due to potential estrogen-like activity
อาการไม่พึงประสงค์
- Gastrointestinal upset (mild nausea, vomiting, diarrhea)
- Allergic reactions in patients sensitive to the Asteraceae/Compositae plant family
- Generally very well tolerated
- Rare mild gastrointestinal upset
อันตรกิริยาระหว่างยา
- CYP2C9 Substrates (e.g., warfarin, amitriptyline, verapamil) · Silymarin may inhibit cytochrome P450 isoenzyme 2C9 (CYP2C9). Use caution with narrow therapeutic index drugs metabolized by this pathway.
- CYP3A4 Substrates · May inhibit CYP3A4, though clinical significance is currently undetermined.
- Drugs undergoing hepatic glucuronidation (acetaminophen, diazepam, morphine, lamotrigine) · Silymarin may increase the clearance of these drugs (not applicable in cats). Clinical significance is undetermined.
การติดตาม
- Clinical efficacy (resolution of clinical signs)
- Liver enzyme panels (ALT, AST, ALP, GGT)
- Hepatic function tests (Bilirubin, Bile Acids, BUN, Albumin)
- Liver enzymes (ALT, AST, ALP, GGT)
- Total bilirubin
- Bile acids
- Clinical signs of hepatic disease (e.g., icterus, lethargy, appetite)
การได้รับยาเกินขนาด
Overdoses are highly unlikely to cause significant morbidity due to the supplement's high safety margin. Mild gastrointestinal effects (vomiting, diarrhea) may be seen and should be treated in a supportive and symptomatic manner.
ข้อมูลอ้างอิงยาของ VetSheet มีไว้สำหรับสัตวแพทย์ผู้มีใบอนุญาตเพื่อช่วยในการตัดสินใจทางคลินิก ไม่ใช่สิ่งทดแทนการวินิจฉัยของผู้เชี่ยวชาญหรือฉลากล่าสุดของผู้ผลิต